Pharmaceutical Enterprises' R&D Strategic Alliance—— the Road for Small and Medium Sized Pharmaceutical Enterprises' R&D in China
- Shuzhen Chu
- Chunmei Sun
Abstract
Based on analyzing the status of small and medium-sized pharmaceutical enterprises in China, the paper explores the problems of these enterprises; Then it provided several feasible development strategies which are building pharmaceutical enterprises' R&D strategic alliance, starting from the corporate strategic view and combining with the R&D characteristics of small and medium sized pharmaceutical companies; Finally in order to ensure the Effectiveness of R & D alliance, we point out some points of what should be noted in the process.
- Full Text: PDF
- DOI:10.5539/ibr.v3n1p131
This work is licensed under a Creative Commons Attribution 4.0 License.
Journal Metrics
h-index (January 2024): 102
i10-index (January 2024): 947
h5-index (January 2024): N/A
h5-median(January 2024): N/A
( The data was calculated based on Google Scholar Citations. Click Here to Learn More. )
Index
- Academic Journals Database
- ACNP
- ANVUR (Italian National Agency for the Evaluation of Universities and Research Institutes)
- CNKI Scholar
- COPAC
- CrossRef
- EBSCOhost
- EconBiz
- ECONIS
- EconPapers
- Elektronische Zeitschriftenbibliothek (EZB)
- EuroPub Database
- Excellence in Research for Australia (ERA)
- Genamics JournalSeek
- Google Scholar
- Harvard Library
- IBZ Online
- IDEAS
- Infotrieve
- Kobson
- LOCKSS
- Mendeley
- MIAR
- Norwegian Centre for Research Data (NSD)
- PKP Open Archives Harvester
- Publons
- Qualis/CAPES
- RePEc
- ResearchGate
- ROAD
- Scilit
- SHERPA/RoMEO
- SocioRePEc
- Technische Informationsbibliothek (TIB)
- The Keepers Registry
- UCR Library
- Universe Digital Library
- ZBW-German National Library of Economics
- Zeitschriften Daten Bank (ZDB)
Contact
- Kevin DuranEditorial Assistant
- ibr@ccsenet.org